Test will help match patients with blood cancer to right treatments

05/3/2013 | Boston Globe (tiered subscription model), The

Foundation Medicine has entered a collaboration with Memorial Sloan-Kettering Cancer Center for the development of a test to help identify the best hematologic cancer treatments for individual patients. The test will employ RNA and DNA sequencing to classify hematologic conditions.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR